[{"edinetCode":"E00963","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1438.0,"averageTemporaryStaff":626.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":19728000.0,"sharesOwendPercent":0.3252,"outstandingShares":null,"numberOfSubsidiary":7.0,"bps":1552.67,"equityRatio":0.322,"cashAndCashEquivalents":14468000000.0,"assets":270890000000.0,"currentAssets":114714000000.0,"fixedAsset":156175000000.0,"tangibleFixedAssets":47439000000.0,"intangibleFixedAssets":93111000000.0,"investmentAndOtherAssets":15625000000.0,"liabilities":183309000000.0,"currentLiabilities":87829000000.0,"shorTermDept":23789000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":6444000000.0,"fixedLiabilities":95480000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":80104000000.0,"netAsset":87580000000.0,"capitalStock":74764000000.0,"capital":19976000000.0,"capitalSurplus":18838000000.0,"accumulatedEarnings":45350000000.0,"treasuryStock":-9401000000.0,"valuationAndConversionAdjustments":12582000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":163372000000.0,"costOfSales":106637000000.0,"grossProfit":56735000000.0,"sgaExpenses":48186000000.0,"salaryAndBenefit":6284000000.0,"depreciationAndSGA":null,"RDExpenses":7263000000.0,"operatingIncome":8554000000.0,"nonOperatingIncome":789000000.0,"nonOperatingExpenses":932000000.0,"interestExpense":294000000.0,"ordinaryProfit":8411000000.0,"extraordinaryGain":381000000.0,"extraordinaryLoss":1861000000.0,"incomeBeforeTax":6930000000.0,"incomeTaxes":2142000000.0,"netIncome":4788000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":4788000000.0,"comprehensiveIncome":14990000000.0,"eps":84.09,"dilutedEps":83.95,"dividendPerShare":null,"per":20.6,"roe":0.056,"cashFlowFromOperatingActivities":3951000000.0,"depreciationAndCashflowFromOperatingActivities":6591000000.0,"cashFlowFromInvestingActivities":-81754000000.0,"cashFlowFromFinancialActivities":64620000000.0,"changesInCashAndCashEquivalents":-13288000000.0,"列1":"asr","submitDate":"2017\/6\/16","stockCode":4541,"accountingYear":"第53期（自　平成28年４月１日　至　平成29年３月31日）","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00963","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":23360,"settlementDate":"2022\/3\/31","submitterName":"日医工株式会社","submitterNameEnglish":"Nichi-Iko Pharmaceutical Co., Ltd.","submitterNameKana":"ニチイコウカブシキガイシャ","location":"富山市総曲輪一丁目６番２１","industory":"医薬品","corporateNumber":1230000000000.0},{"edinetCode":"E00963","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1560.0,"averageTemporaryStaff":666.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":17168000.0,"sharesOwendPercent":0.301,"outstandingShares":null,"numberOfSubsidiary":null,"bps":1448.96,"equityRatio":0.303,"cashAndCashEquivalents":17993000000.0,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":242000000.0,"eps":68.49,"dilutedEps":68.36,"dividendPerShare":null,"per":24.5,"roe":0.046,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2018\/6\/15","stockCode":4541,"accountingYear":"第54期（自　2017年４月１日　至　2018年３月31日）","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00963","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":23360,"settlementDate":"2022\/3\/31","submitterName":"日医工株式会社","submitterNameEnglish":"Nichi-Iko Pharmaceutical Co., Ltd.","submitterNameKana":"ニチイコウカブシキガイシャ","location":"富山市総曲輪一丁目６番２１","industory":"医薬品","corporateNumber":1230000000000.0},{"edinetCode":"E00963","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1573.0,"averageTemporaryStaff":679.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":21322000.0,"sharesOwendPercent":0.3322,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":306838000000.0,"currentAssets":142722000000.0,"fixedAsset":null,"tangibleFixedAssets":55710000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":190514000000.0,"currentLiabilities":91837000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":23360000000.0,"capitalSurplus":21896000000.0,"accumulatedEarnings":55016000000.0,"treasuryStock":-2893000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":133434000000.0,"grossProfit":null,"sgaExpenses":22504000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":12.7,"roe":null,"cashFlowFromOperatingActivities":23811000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-24983000000.0,"cashFlowFromFinancialActivities":24803000000.0,"changesInCashAndCashEquivalents":23564000000.0,"列1":"asr","submitDate":"2019\/6\/21","stockCode":4541,"accountingYear":"第55期（自　2018年４月１日　至　2019年３月31日）","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00963","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":23360,"settlementDate":"2022\/3\/31","submitterName":"日医工株式会社","submitterNameEnglish":"Nichi-Iko Pharmaceutical Co., Ltd.","submitterNameKana":"ニチイコウカブシキガイシャ","location":"富山市総曲輪一丁目６番２１","industory":"医薬品","corporateNumber":1230000000000.0},{"edinetCode":"E00963","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":312848000000.0,"currentAssets":150761000000.0,"fixedAsset":null,"tangibleFixedAssets":58041000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":198604000000.0,"currentLiabilities":100164000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":23360000000.0,"capitalSurplus":21890000000.0,"accumulatedEarnings":55787000000.0,"treasuryStock":-2854000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":36830000000.0,"grossProfit":null,"sgaExpenses":6698000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":7659000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-8573000000.0,"cashFlowFromFinancialActivities":-3741000000.0,"changesInCashAndCashEquivalents":-4828000000.0,"列1":"q1r","submitDate":"2019\/8\/13","stockCode":4541,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00963","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":23360,"settlementDate":"2022\/3\/31","submitterName":"日医工株式会社","submitterNameEnglish":"Nichi-Iko Pharmaceutical Co., Ltd.","submitterNameKana":"ニチイコウカブシキガイシャ","location":"富山市総曲輪一丁目６番２１","industory":"医薬品","corporateNumber":1230000000000.0},{"edinetCode":"E00963","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":22377000.0,"sharesOwendPercent":0.3485,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":316789000000.0,"currentAssets":149563000000.0,"fixedAsset":null,"tangibleFixedAssets":58483000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":200657000000.0,"currentLiabilities":104522000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":23360000000.0,"capitalSurplus":21866000000.0,"accumulatedEarnings":56873000000.0,"treasuryStock":-2706000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":72509000000.0,"grossProfit":null,"sgaExpenses":12980000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":11732000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-13370000000.0,"cashFlowFromFinancialActivities":-6120000000.0,"changesInCashAndCashEquivalents":-7684000000.0,"列1":"q2r","submitDate":"2019\/11\/13","stockCode":4541,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00963","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":23360,"settlementDate":"2022\/3\/31","submitterName":"日医工株式会社","submitterNameEnglish":"Nichi-Iko Pharmaceutical Co., Ltd.","submitterNameKana":"ニチイコウカブシキガイシャ","location":"富山市総曲輪一丁目６番２１","industory":"医薬品","corporateNumber":1230000000000.0},{"edinetCode":"E00963","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":323435000000.0,"currentAssets":153346000000.0,"fixedAsset":null,"tangibleFixedAssets":58237000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":204370000000.0,"currentLiabilities":109102000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":23360000000.0,"capitalSurplus":21858000000.0,"accumulatedEarnings":58337000000.0,"treasuryStock":-2665000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":113334000000.0,"grossProfit":null,"sgaExpenses":18773000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":14763000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-16589000000.0,"cashFlowFromFinancialActivities":-5386000000.0,"changesInCashAndCashEquivalents":-7343000000.0,"列1":"q3r","submitDate":"2020\/2\/14","stockCode":4541,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00963","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":23360,"settlementDate":"2022\/3\/31","submitterName":"日医工株式会社","submitterNameEnglish":"Nichi-Iko Pharmaceutical Co., Ltd.","submitterNameKana":"ニチイコウカブシキガイシャ","location":"富山市総曲輪一丁目６番２１","industory":"医薬品","corporateNumber":1230000000000.0},{"edinetCode":"E00963","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1954.0,"averageTemporaryStaff":685.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":21875000.0,"sharesOwendPercent":0.3407,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":336819000000.0,"currentAssets":164708000000.0,"fixedAsset":null,"tangibleFixedAssets":59201000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":219648000000.0,"currentLiabilities":122690000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":23360000000.0,"capitalSurplus":21896000000.0,"accumulatedEarnings":57365000000.0,"treasuryStock":-2562000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":152756000000.0,"grossProfit":null,"sgaExpenses":25614000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":17.7,"roe":null,"cashFlowFromOperatingActivities":18450000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-18228000000.0,"cashFlowFromFinancialActivities":1002000000.0,"changesInCashAndCashEquivalents":850000000.0,"列1":"asr","submitDate":"2020\/6\/24","stockCode":4541,"accountingYear":"第56期（自　2019年４月１日　至　2020年３月31日）","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00963","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":23360,"settlementDate":"2022\/3\/31","submitterName":"日医工株式会社","submitterNameEnglish":"Nichi-Iko Pharmaceutical Co., Ltd.","submitterNameKana":"ニチイコウカブシキガイシャ","location":"富山市総曲輪一丁目６番２１","industory":"医薬品","corporateNumber":1230000000000.0},{"edinetCode":"E00963","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":327478000000.0,"currentAssets":153133000000.0,"fixedAsset":null,"tangibleFixedAssets":59565000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":211162000000.0,"currentLiabilities":115921000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":23360000000.0,"capitalSurplus":21896000000.0,"accumulatedEarnings":56583000000.0,"treasuryStock":-2538000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":37178000000.0,"grossProfit":null,"sgaExpenses":6712000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":4545000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-5883000000.0,"cashFlowFromFinancialActivities":-3614000000.0,"changesInCashAndCashEquivalents":-5301000000.0,"列1":"q1r","submitDate":"2020\/8\/13","stockCode":4541,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00963","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":23360,"settlementDate":"2022\/3\/31","submitterName":"日医工株式会社","submitterNameEnglish":"Nichi-Iko Pharmaceutical Co., Ltd.","submitterNameKana":"ニチイコウカブシキガイシャ","location":"富山市総曲輪一丁目６番２１","industory":"医薬品","corporateNumber":1230000000000.0},{"edinetCode":"E00963","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":21428000.0,"sharesOwendPercent":0.3337,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":327226000000.0,"currentAssets":153007000000.0,"fixedAsset":null,"tangibleFixedAssets":58938000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":212184000000.0,"currentLiabilities":119332000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":23360000000.0,"capitalSurplus":21896000000.0,"accumulatedEarnings":56337000000.0,"treasuryStock":-2435000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":73950000000.0,"grossProfit":null,"sgaExpenses":13074000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1119000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-8945000000.0,"cashFlowFromFinancialActivities":283000000.0,"changesInCashAndCashEquivalents":-7599000000.0,"列1":"q2r","submitDate":"2020\/11\/13","stockCode":4541,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00963","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":23360,"settlementDate":"2022\/3\/31","submitterName":"日医工株式会社","submitterNameEnglish":"Nichi-Iko Pharmaceutical Co., Ltd.","submitterNameKana":"ニチイコウカブシキガイシャ","location":"富山市総曲輪一丁目６番２１","industory":"医薬品","corporateNumber":1230000000000.0},{"edinetCode":"E00963","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":325929000000.0,"currentAssets":151567000000.0,"fixedAsset":null,"tangibleFixedAssets":58479000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":213407000000.0,"currentLiabilities":122252000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":23360000000.0,"capitalSurplus":21896000000.0,"accumulatedEarnings":54860000000.0,"treasuryStock":-2319000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":115802000000.0,"grossProfit":null,"sgaExpenses":19748000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":3249000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-14408000000.0,"cashFlowFromFinancialActivities":-1925000000.0,"changesInCashAndCashEquivalents":-13150000000.0,"列1":"q3r","submitDate":"2021\/2\/12","stockCode":4541,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00963","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":23360,"settlementDate":"2022\/3\/31","submitterName":"日医工株式会社","submitterNameEnglish":"Nichi-Iko Pharmaceutical Co., Ltd.","submitterNameKana":"ニチイコウカブシキガイシャ","location":"富山市総曲輪一丁目６番２１","industory":"医薬品","corporateNumber":1230000000000.0},{"edinetCode":"E00963","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2725.0,"averageTemporaryStaff":790.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":20438000.0,"sharesOwendPercent":0.3183,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":363572000000.0,"currentAssets":175102000000.0,"fixedAsset":null,"tangibleFixedAssets":68943000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":251136000000.0,"currentLiabilities":143574000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":23360000000.0,"capitalSurplus":21896000000.0,"accumulatedEarnings":50822000000.0,"treasuryStock":-2267000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":166973000000.0,"grossProfit":null,"sgaExpenses":27029000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":5006000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-29334000000.0,"cashFlowFromFinancialActivities":10867000000.0,"changesInCashAndCashEquivalents":-13801000000.0,"列1":"asr","submitDate":"2021\/6\/18","stockCode":4541,"accountingYear":"第57期（自　2020年４月１日　至　2021年３月31日）","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00963","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":23360,"settlementDate":"2022\/3\/31","submitterName":"日医工株式会社","submitterNameEnglish":"Nichi-Iko Pharmaceutical Co., Ltd.","submitterNameKana":"ニチイコウカブシキガイシャ","location":"富山市総曲輪一丁目６番２１","industory":"医薬品","corporateNumber":1230000000000.0},{"edinetCode":"E00963","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":354607000000.0,"currentAssets":165707000000.0,"fixedAsset":null,"tangibleFixedAssets":66834000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":246586000000.0,"currentLiabilities":140564000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":23360000000.0,"capitalSurplus":21896000000.0,"accumulatedEarnings":46272000000.0,"treasuryStock":-2216000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":39420000000.0,"grossProfit":null,"sgaExpenses":6879000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-14497000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-1024000000.0,"cashFlowFromFinancialActivities":287000000.0,"changesInCashAndCashEquivalents":-15439000000.0,"列1":"q1r","submitDate":"2021\/8\/13","stockCode":4541,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00963","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":23360,"settlementDate":"2022\/3\/31","submitterName":"日医工株式会社","submitterNameEnglish":"Nichi-Iko Pharmaceutical Co., Ltd.","submitterNameKana":"ニチイコウカブシキガイシャ","location":"富山市総曲輪一丁目６番２１","industory":"医薬品","corporateNumber":1230000000000.0},{"edinetCode":"E00963","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":27392000.0,"sharesOwendPercent":0.3889,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":365080000000.0,"currentAssets":174589000000.0,"fixedAsset":null,"tangibleFixedAssets":66331000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":262742000000.0,"currentLiabilities":143691000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":25975000000.0,"capitalSurplus":24511000000.0,"accumulatedEarnings":35084000000.0,"treasuryStock":-2124000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":85079000000.0,"grossProfit":null,"sgaExpenses":13483000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-19859000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-7680000000.0,"cashFlowFromFinancialActivities":23517000000.0,"changesInCashAndCashEquivalents":-4177000000.0,"列1":"q2r","submitDate":"2021\/11\/12","stockCode":4541,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00963","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":23360,"settlementDate":"2022\/3\/31","submitterName":"日医工株式会社","submitterNameEnglish":"Nichi-Iko Pharmaceutical Co., Ltd.","submitterNameKana":"ニチイコウカブシキガイシャ","location":"富山市総曲輪一丁目６番２１","industory":"医薬品","corporateNumber":1230000000000.0},{"edinetCode":"E00963","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":360595000000.0,"currentAssets":167886000000.0,"fixedAsset":null,"tangibleFixedAssets":65767000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":257857000000.0,"currentLiabilities":150410000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":25975000000.0,"capitalSurplus":24511000000.0,"accumulatedEarnings":33864000000.0,"treasuryStock":-2124000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":127898000000.0,"grossProfit":null,"sgaExpenses":19835000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-24893000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-9276000000.0,"cashFlowFromFinancialActivities":22223000000.0,"changesInCashAndCashEquivalents":-12390000000.0,"列1":"q3r","submitDate":"2022\/2\/14","stockCode":4541,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00963","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":23360,"settlementDate":"2022\/3\/31","submitterName":"日医工株式会社","submitterNameEnglish":"Nichi-Iko Pharmaceutical Co., Ltd.","submitterNameKana":"ニチイコウカブシキガイシャ","location":"富山市総曲輪一丁目６番２１","industory":"医薬品","corporateNumber":1230000000000.0}]